Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study
Abstract Background Immunocompromised patients face higher risks of Severe Acute Respiratory Syndrome Coronavirus 2 infection and co-infections, leading to a possibility of high disease severity and poor outcomes. Conversely, immunosuppression can mitigate the excessive inflammatory response induced...
Saved in:
| Main Authors: | Chunyan Li, Hangyong He, Yuqiong Wang, Linna Huang, Ziying Chen, Qi Zhang, Ying Cai, Tianshu Zhai, Xiaojing Wu, Qingyuan Zhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-024-03362-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corticosteroids in immunocompromised ICU patients with severe COVID-19: a multicenter retrospective study
by: Claire Dupuis, et al.
Published: (2025-07-01) -
The At-Admission fT3/fT4 Ratio Could Predict the Prognosis of Patients Admitted to Surgical ICU
by: Yehya Shahin Dabour *, et al.
Published: (2024-07-01) -
Advocating for the recognition of underlying immunosuppression in critical illness
by: Ignacio Martin-Loeches, et al.
Published: (2025-07-01) -
The effects of saffron supplementation on inflammatory factors and clinical outcomes in sepsis patients admitted to the intensive care unit (ICU): Study protocol for a double-blind randomized controlled clinical trial
by: Shirin Hassanizadeh, et al.
Published: (2025-06-01) -
Perspectives of ICU Physicians on Antibiotic Use in Critically Ill Patients: A Qualitative Study from a Developing Country
by: Maheen Khoso, et al.
Published: (2025-06-01)